Evidence map›Paper›PMID 36082766›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Robert R A Bolt, Sarah E Raby-Buck, Katharine Ingram, Jamie A Leitch, Duncan L Browne

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Angewandte Chemie (International ed. in English) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Robert R A BoltDepartment of Pharmaceutical and Biological Chemistry, University College London (UCL), School of Pharmacy, 29-39 Brunswick Square, Bloomsbury, London, WC1N 1AX, UK.ORCID http://orcid.org/0000-0002-9721-4931
Sarah E Raby-BuckDepartment of Pharmaceutical and Biological Chemistry, University College London (UCL), School of Pharmacy, 29-39 Brunswick Square, Bloomsbury, London, WC1N 1AX, UK.ORCID http://orcid.org/0000-0003-2561-3885
Katharine IngramSyngenta, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.
Jamie A LeitchDepartment of Pharmaceutical and Biological Chemistry, University College London (UCL), School of Pharmacy, 29-39 Brunswick Square, Bloomsbury, London, WC1N 1AX, UK.ORCID http://orcid.org/0000-0001-6997-184X
Duncan L BrowneDepartment of Pharmaceutical and Biological Chemistry, University College London (UCL), School of Pharmacy, 29-39 Brunswick Square, Bloomsbury, London, WC1N 1AX, UK.ORCID http://orcid.org/0000-0002-8604-229X

Funding

Engineering and Physical Sciences Research Council EP/W522077/1Leverhulme Trust RPG-2019-069
6 · The paper itself

Abstract

The nickel catalyzed Suzuki-Miyaura-type coupling of aryl sulfamates and boronic acid derivatives enabled by temperature-controlled mechanochemistry via the development of a programmable PID-controlled jar heater is reported. This base-metal-catalyzed, solvent-free, all-under-air protocol was also scaled 200-fold using twin-screw extrusion technology affording decagram quantities of material.

Indexed as

Cross-CouplingMechanochemistryNickel CatalysisTwin-Screw Extrusion

Identifiers

PMID36082766
PMCPMC9828252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.